Aristotle University Of Thessaloniki (AUTH)
Σύνθεση και μελέτη νέων παραγώγων της ιβουπροφαίνης και της προλίνης με πιθανή πολύπλευρη δράση κατά της νόσου alzheimer
Abstract
dc:descriptionNeurodegenerative disorders such as Alzheimer’s disease (AD), along with cardiovascular diseases and cancer, are the top causes of morbidity and they are estimated to affect more than 37 million of people worldwide by the year 2020. Therefore, it appears interesting to design and synthesise molecules for the treatment of AD. Moreover, it is a pharmacochemical challenge, since there is still enough uncertainty about the molecular pathogenesis of nerve cell death and there has not been a really effective intervention yet. However, there is a series of pathobiochemical changes in the demented brain, which could be used as a starting point for rational design of molecules for the particular condition. Thus, the appearance of neurofibrillary tangles intracellularly, amyloid plaques extracellularly, a serious cholinergic deficit, oxidative stress, inflammation, reduction of nerve growth factor, increased apolipoprotein E4 and hypercholesterolemia are interrelated factors contributing to cell death in AD. Furthermore, the possible neuroprotective role of nitric oxide radical (•NO) in AD as well as the ability of NO-donors to delay the development of the disease are well established. Consequently, there are several targets for the medicinal treatment of cognition disorders and the potential of multifunctional therapeutic agents for the treatment of complex neurodegenerative diseases has already been considered. In this work, we describe the synthesis of derivatives of ibuprofen, a known non steroidal anti-inflammatory drug which has also been found to affect amyloid pathology in the brain and its long-term use has been associated with reduced risk of neurodegeneration. Ibuprofen is connected, via an amide bond, with an L-proline moiety, expected to contribute to the nootropic properties, since structurally related amides or esters of proline have some nootropic action and proline dipeptides have been found to be about 2000 times more potent than piracetam. Proline carboxylic group has further been converted to amide with L-cysteine ethyl ester and cysteamine, known antioxidants with low general toxicity. In addition, the carboxylic group of the intermediate proline amide has been esterified with 3-(3-hydroxypropyl)pyridine and 2-methoxy-4-methylphenol, expected to offer neurotrophic and/or neuroprotective activity. Moreover, in order to enlighten the contribution of pyridyl ring of the 3-(3-hydroxypropyl)pyridine moiety, the carboxylic group of the intermediate proline amide has been esterified with 3-phenylpropan-1-ol while esterification with 2-bromoethanol and further reaction with silver nitrate has led to the synthesis of a nitric ester. Its hydrolysis during the isolation process has offered the opportunity to estimate the importance of the nitrooxy group. In addition, ibuprofen has directly been esterified with 3-(3-hydroxypropyl)pyridine and 2-methoxy-4-methylphenol in an attempt to investigate the contribution of the L-proline residue to the molecular activity. Finally, the L-proline amide with isobutyric acid has been prepared and esterified with 3-(3-hydroxypropyl)pyridine and 2-methoxy-4-methylphenol, facilitating to determine the importance of the ibuprofen moiety. The structures of all synthesised compounds were identified by elemental analysis (C, H, N) and spectroscopically (IR, 1H-NMR).
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Σίσκου, Ιωάννα
- Siskou, Ioanna
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/15400